Cargando…
Natural Products as Source of Potential Dengue Antivirals
Dengue is a neglected disease responsible for 22,000 deaths each year in areas where it is endemic. To date, there is no clinically approved dengue vaccine or antiviral for human beings, even though there have been great efforts to accomplish these goals. Several approaches have been used in the sea...
Autores principales: | Teixeira, Róbson Ricardo, Pereira, Wagner Luiz, Oliveira, Ana Flávia Costa da Silveira, da Silva, Adalberto Manoel, de Oliveira, André Silva, da Silva, Milene Lopes, da Silva, Cynthia Cânedo, de Paula, Sérgio Oliveira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271820/ https://www.ncbi.nlm.nih.gov/pubmed/24941340 http://dx.doi.org/10.3390/molecules19068151 |
Ejemplares similares
-
Potential Antivirals: Natural Products Targeting Replication Enzymes of Dengue and Chikungunya Viruses
por: Oliveira, Ana Flávia Costa da Silveira, et al.
Publicado: (2017) -
Evaluation of Antiviral Activity of Cyclic Ketones against Mayaro Virus
por: Fernandes, Luciana S., et al.
Publicado: (2021) -
Efficient Plant Production of Recombinant NS1 Protein for Diagnosis of Dengue
por: Xisto, Mariana Fonseca, et al.
Publicado: (2020) -
NS1 Recombinant Proteins Are Efficiently Produced in Pichia pastoris and Have Great Potential for Use in Diagnostic Kits for Dengue Virus Infections
por: Xisto, Mariana Fonseca, et al.
Publicado: (2020) -
Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds
por: de Oliveira, André S., et al.
Publicado: (2019)